---
title: "Kingchem (Liaoning) Life Science Co., Ltd. (301509.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301509.SZ.md"
symbol: "301509.SZ"
name: "Kingchem (Liaoning) Life Science Co., Ltd."
industry: "Pharmaceuticals"
datetime: "2026-05-21T16:51:27.002Z"
locales:
  - [en](https://longbridge.com/en/quote/301509.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301509.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301509.SZ.md)
---

# Kingchem (Liaoning) Life Science Co., Ltd. (301509.SZ)

## Company Overview

Kingchem (Liaoning) Life Science Co., Ltd. engages in the provision of small molecule CDMO services for life science customers in China and internationally. The company offers fluorine-containing products, such as trifluoromethoxy or trifluoromethyl benzene intermediates, and fluorinated aromatic ring intermediates. It also provides non-fluorinated products, including nitrogen-containing heterocyclic series, aliphatic organic derivatives of ammonia, carboxylic acids and their derivatives, olefins, nonfluorinated halogenated benzenes, phenols, ketones, and isocyanates.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | CN Market |
| Website | [www.kingchemchina.com](https://www.kingchemchina.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:13.000Z

**Overall: B (0.38)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 58 / 215 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 11.31% |  |
| Net Profit YoY | 6.85% |  |
| P/B Ratio | 1.81 |  |
| Dividend Ratio | 1.20% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 4004365726.10 |  |
| Revenue | 609964485.96 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 3.35% | C |
| Profit Margin | 12.11% | B |
| Gross Margin | 42.34% | B |
| Revenue YoY | 11.31% | B |
| Net Profit YoY | 6.85% | C |
| Total Assets YoY | 1.12% | C |
| Net Assets YoY | 1.17% | C |
| Cash Flow Margin | 189.31% | B |
| OCF YoY | 11.31% | B |
| Turnover | 0.26 | D |
| Gearing Ratio | 5.00% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Kingchem (Liaoning) Life Science Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "11.31%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "6.85%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.81",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "1.20%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "4004365726.10",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "609964485.96",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "3.35%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "12.11%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "42.34%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "11.31%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "6.85%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "1.12%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "1.17%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "189.31%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "11.31%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.26",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "5.00%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 51.92 | 107/215 | 64.88 | 54.13 | 43.47 |
| PB | 1.73 | 65/215 | 2.18 | 2.07 | 1.91 |
| PS (TTM) | 6.29 | 146/215 | 8.43 | 7.75 | 7.03 |
| Dividend Yield | 1.25% | 94/215 | 1.14% | 1.06% | 1.00% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Allist (688578.SH) | A | A | B | A | B | A |
| 02 | Xingqi Pharmaceutical (300573.SZ) | A | A | A | A | B | A |
| 03 | Hengrui Pharma (600276.SH) | A | B | C | A | B | B |
| 04 | Yunnan Baiyao (000538.SZ) | B | C | B | B | C | B |
| 05 | Haisco (002653.SZ) | A | A | B | B | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/301509.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/301509.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/301509.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/301509.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**